Latest Commercialization News

Estrella Resources has reported significant high-grade manganese intersections at its Ira Miri project and initiated a major limestone drilling campaign at Werumata, marking a pivotal quarter in its Timor-Leste exploration efforts.

Lunnon Metals has completed key de-risking at its Lady Herial gold deposit and executed a pivotal Ore Purchase Agreement with Gold Fields, securing a 70% share of future free cash flow. The company maintains a strong cash position while advancing multiple gold prospects and confirming nickel asset viability.

Finder Energy has locked in a significant funding agreement with TIMOR GAP, securing half of the KTJ Project’s development capex and upgrading its resource base, setting the stage for a Final Investment Decision by mid-2026.

Adisyn Ltd has strengthened its position in semiconductor innovation by commissioning a cutting-edge Atomic Layer Deposition system, accelerating its graphene interconnect development while maintaining a robust cash reserve.

Sprintex Limited has transitioned from development to commercial execution, securing major contracts in Europe, China, and India while raising A$1.5m to fund expansion.

Industrial Minerals Ltd has announced a maiden inferred mineral resource estimate of 6.2 million tonnes at 98% silica for its Pippingarra Quarry Project, alongside successful testwork and a 12-month option extension.

Patriot Resources has validated high-grade copper mineralisation at its Kitumba project in Zambia and discontinued its Sugarloaf option, refocusing capital on core assets while planning 2026 drilling backed by ongoing capital raise talks.

Volt Resources has secured strategic funding and relocated its US operations to Alabama, advancing its graphite refinery ambitions while winning a key legal battle in Ukraine.

Revolver Resources has completed a key drilling program at its Dianne Copper Mine Project, affirming resource estimates and progressing towards a targeted production restart in late 2026. The company also secured significant funding to support upcoming development milestones.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for chronic wound treatment and advances regulatory filings for its TR Pro+® product, while gearing up for a major commercial rollout in early 2026.

Resonance Health reports positive cash flow and significant progress in its clinical trials and Software-as-a-Medical Device business, setting the stage for growth in new international markets.

Green Critical Minerals advances its Very High Density graphite technology with strong thermal performance validation, production scale-up, and strategic moves into global markets including a planned US listing.